2016


Aargau


@InterAxBiotech Homepage

Company profile

InterAx Biotech

Drugs work by binding to receptors and thereby triggering a specific reaction by the affected cell. InterAx has developed technology that can more accurately determine the reaction of receptors to which 40% of all drugs bind. This makes it possible to find active ingredients that are more effective and have fewer side-effects.


Source: startup.ch

Highlights

More news about InterAx Biotech

15.01.2019 16:40

InterAx Biotech closed a financing round of CHF 3 million

Financing
Please login or
register to use the
bookmark feature
09.05.2018 16:20

Ten startup founders are set for China

Award
Please login or
register to use the
bookmark feature
19.04.2018 11:52

Two Swiss start-ups pave a new way to cancer drugs

Expansion
Please login or
register to use the
bookmark feature
24.10.2016 13:59

Die Finalisten des Swiss Technology Award stehen fest

Award
Please login or
register to use the
bookmark feature
21.10.2016 14:24

Unternehmenswettbewerb «SWISS UPSTART»: Die Preisträger

Award
Please login or
register to use the
bookmark feature
06.04.2016 16:45

Venturelab presents the 20 Venture leaders of 2016

AwardSupport
Please login or
register to use the
bookmark feature

Principal

A showcase for female CEOs


Startupticker has recorded Swiss start-ups with female CEOs and ranked them by sector. The map which includes links to 80+ companies can be downloaded in our article.

Partners

Contributors

By continuing to use this website you agree with our TERMS AND CONDITIONS